SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.
- DOI
- 10.1016/j.lfs.2021.119646
- Published
- 2021 Aug 1
- Container
- Life sciences
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lfs.2021.119646,
title = {SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.},
author = {Joviano-Santos JV and Santos-Miranda A and Neri EA and Fonseca-Alaniz MH and Krieger JE and Pereira AC and Roman-Campos D},
year = {2021},
journal = {Life sciences},
doi = {10.1016/j.lfs.2021.119646},
url = {https://doi.org/10.1016/j.lfs.2021.119646}
}RIS
TY - JOUR TI - SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment. AU - Joviano-Santos JV AU - Santos-Miranda A AU - Neri EA AU - Fonseca-Alaniz MH AU - Krieger JE AU - Pereira AC AU - Roman-Campos D PY - 2021 JO - Life sciences DO - 10.1016/j.lfs.2021.119646 UR - https://doi.org/10.1016/j.lfs.2021.119646 ER -
APA
JV, J., A, S., EA, N., MH, F., JE, K., AC, P., & D, R. (2021). SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.. Life sciences. https://doi.org/10.1016/j.lfs.2021.119646
Source records
- pubmed · retrieved 2026-09-26T01:20:58.892Z